BRAIN Biotech AG Cash Flow Reinvestment Rate
Latest as of June 2024:
2.58x
BRAIN Biotech AG cash flow reinvestment rate. BRAIN Biotech AG (BNN) has a Cash Flow Reinvestment Rate of 2.58x as of June 2024, reinvesting €1.33 Million (capex €720.00K plus investments €-609.00K) from operating cash flow of €516.00K. Explore cash flow to debt ratio of BRAIN Biotech AG to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
2.58x
(Capex + Investments) / Operating CF
Total Reinvested
€1.33 Million
Capex + Investments
Operating Cash Flow
€516.00K
EUR
Capital Expenditures
€720.00K
EUR
BRAIN Biotech AG Cash Flow Reinvestment Rate by Year (None–None)
BRAIN Biotech AG cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for BRAIN Biotech AG. For the full cash flow conversion analysis, see BNN operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow